HCV ADVOCATE WEEKLY NEWS REVIEW

[Guest guest]

HCV ADVOCATE WEEKLY NEWS REVIEW

Week Ending: June 5, 2010

This Issue:

Beacon Pharma Launches Anti-Hepatitis Medicine Screening for Liver Cancer in HIV/HCV Coinfected People Australian Police Probe Hepatitis Cluster at Abortion Clinic Hep C Fund Runs Dry, Family Out of Luck Can-Fite’s Drug CF102 Significantly Decreased Viral Load of HCV in a Patient with Liver Cancer Informational Video on Hepatitis B (Cantonese) Researchers Fine-Tune Hepatitis B Trials Hepatitis Survivor: 'I Was Lucky' ZymoGenetics Initiates PEG-Interferon lambda Phase 2b Clinical Trial in Hepatitis C in Collaboration with Bristol-Myers Squibb 55 Women at Risk of Hep C Being Traced NVHR Applauds World Health Organization Resolution Calling For Comprehensive Strategy to Fight Viral Hepatitis Worldwide FDA Approves Qualitative Anti-HCV Immunoassay Physicians May Use Risk-Based Screening Strategy to Identify Hepatitis C Virus Infection ECMC Receives Portion of Hepatitis C Funds Man's Death Tied to 2002 Hepatitis Outbreak HEPATITIS C CASE: Prosecutors Seek Indictment against Desai, Two Others on Criminal Charges Hepatitis Cases Discovered Family Raising Funds for Father’s Liver Transplant Hepatitis B Campaign Targets Asians in San Francisco

http://www.hcvadvocate.org/news/newsRev/2010/NewsRev-364.html